215 related articles for article (PubMed ID: 3124003)
1. Folic acid metabolism and its disruption by pharmacologic agents.
Huennekens FM; Duffy TH; Vitols KS
NCI Monogr; 1987; (5):1-8. PubMed ID: 3124003
[TBL] [Abstract][Full Text] [Related]
2. Elevation of dihydrofolate reductase, thymidylate synthetase, and thymidine kinase in cultured mammalian cells after exposure to folate antagonists.
Chello PL; McQueen CA; DeAngelis LM; Bertino JR
Cancer Res; 1976 Jul; 36(7 PT 1):2442-9. PubMed ID: 1277151
[TBL] [Abstract][Full Text] [Related]
3. Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM.
Pizzorno G; Moroson BA; Cashmore AR; Russello O; Mayer JR; Galivan J; Bunni MA; Priest DG; Beardsley GP
Cancer Res; 1995 Feb; 55(3):566-73. PubMed ID: 7834626
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of folate antagonists versus enzymatic folate depletion on folate and thymidine enzymes in cultured mammalian cells.
Chello PL; McQueen CA; DeAngelis LM; Bertino JR
Cancer Treat Rep; 1977 Jul; 61(4):539-48. PubMed ID: 195727
[No Abstract] [Full Text] [Related]
5. [Mathematical description and study of the folic acid cycle reactions].
Vorontsov IN; Greshilov MM; Belousova AK; Gerasimova GK
Biokhimiia; 1980 Jan; 45(1):83-97. PubMed ID: 6783126
[TBL] [Abstract][Full Text] [Related]
6. Regulation of human dihydrofolate reductase activity and expression.
Abali EE; Skacel NE; Celikkaya H; Hsieh YC
Vitam Horm; 2008; 79():267-92. PubMed ID: 18804698
[TBL] [Abstract][Full Text] [Related]
7. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
Senkovich O; Schormann N; Chattopadhyay D
Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
[TBL] [Abstract][Full Text] [Related]
8. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
Rhee MS; Galivan J; Wright JE; Rosowsky A
Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264
[TBL] [Abstract][Full Text] [Related]
9. Regulatory control of tetrahydrofolate coenzymes in folate auxotrophs.
Albrecht AM
Cancer Treat Rep; 1977 Jul; 61(4):533-8. PubMed ID: 301776
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of biochemical criteria for sensitivity of tumor cells to methotrexate by means of mathematic simulation].
Belousova AK; Gerasimova GK; Vorontsov IN; Greshilov MM
Biokhimiia; 1980 Apr; 45(4):609-21. PubMed ID: 6769505
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of antifolate resistance.
Assaraf YG
Cancer Metastasis Rev; 2007 Mar; 26(1):153-81. PubMed ID: 17333344
[TBL] [Abstract][Full Text] [Related]
12. Design and rationale for novel antifolates.
Bertino JR; Sobrero A; Mini E; Moroson BA; Cashmore A
NCI Monogr; 1987; (5):87-91. PubMed ID: 3431593
[TBL] [Abstract][Full Text] [Related]
13. LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes.
Shih C; Chen VJ; Gossett LS; Gates SB; MacKellar WC; Habeck LL; Shackelford KA; Mendelsohn LG; Soose DJ; Patel VF; Andis SL; Bewley JR; Rayl EA; Moroson BA; Beardsley GP; Kohler W; Ratnam M; Schultz RM
Cancer Res; 1997 Mar; 57(6):1116-23. PubMed ID: 9067281
[TBL] [Abstract][Full Text] [Related]
14. Folate metabolic pathways in Leishmania.
Vickers TJ; Beverley SM
Essays Biochem; 2011; 51():63-80. PubMed ID: 22023442
[TBL] [Abstract][Full Text] [Related]
15. Role of methotrexate polyglutamylation and cellular energy metabolism in inhibition of methotrexate binding to dihydrofolate reductase by 5-formyltetrahydrofolate in Ehrlich ascites tumor cells in vitro.
Matherly LH; Fry DW; Goldman ID
Cancer Res; 1983 Jun; 43(6):2694-9. PubMed ID: 6189586
[TBL] [Abstract][Full Text] [Related]
16. Computer modelling of antifolate inhibition of folate metabolism using hybrid functional petri nets.
Assaraf YG; Ifergan I; Kadry WN; Pinter RY
J Theor Biol; 2006 Jun; 240(4):637-47. PubMed ID: 16352313
[TBL] [Abstract][Full Text] [Related]
17. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM
Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626
[TBL] [Abstract][Full Text] [Related]
18. Interaction of thymidylate synthetase and dihydrofolate reductase enzymes in vitro and in vivo.
Kawai M; Hillcoat BL
Cancer Res; 1974 Jul; 34(7):1619-26. PubMed ID: 4833915
[No Abstract] [Full Text] [Related]
19. Folate and antifolate pharmacology.
Kamen B
Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-30-S18-39. PubMed ID: 9420019
[TBL] [Abstract][Full Text] [Related]
20. Sequential methotrexate and 5-fluorouracil: mechanisms of synergy.
Bertino JR; Mini E; Fernandes DJ
Semin Oncol; 1983 Jun; 10(2 Suppl 2):2-5. PubMed ID: 6867754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
